KALA

KALA

USD

KALA BIO Inc. Common Stock

$0.751+0.011 (1.527%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.740

Hoch

$0.800

Tief

$0.740

Volumen

0.08M

Unternehmensfundamentaldaten

Marktkapitalisierung

5.3M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.11M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.74Aktuell $0.751Hoch $20.6

Ähnliche Nachrichten

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio with a Buy and raises the price target from $12 to $35.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35
Analyst Upgrades

Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio with a Outperform and raises the price target from $15 to $33.

Mehr anzeigen
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33
Analyst Upgrades

Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio with a Outperform rating and announces Price Target of $30.

Mehr anzeigen
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30
GlobeNewswire

KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director

ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for

Mehr anzeigen
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director